Pembrolizumab-induced vasculitis demonstrated by FDG-PET/CT.

Tuan Vu1,2, Sophia R O'Brien1, Shawn X Ma1

  • 1Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19147, USA.

PubMed
Summary

Pembrolizumab, an immune checkpoint inhibitor, can cause vasculitis. Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) identified vasculitis in an immunotherapy patient, which resolved with treatment.